Jeffery Lynn Miller
Physician at Windsor Vw Dr, Rockville, MD
License number
Colorado 28397
Issued Date
Sep 4, 1987
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
10220 Windsor View Dr, Rockville, MD 20854
Personal information
See more information about Jeffery Lynn Miller at radaris.comName
Address
Phone
5220 York Rd, Baltimore, MD 21212
3913 Freedom Ct, Aberdeen Proving Ground, MD 21005
700 Small Reward Rd, Huntingtown, MD 20639
38 Nina Ct, Gaithersburg, MD 20877
35 Lincoln Woods, Perry Hall, MD 21128
Professional information
See more information about Jeffery Lynn Miller at trustoria.com
Methods For Delivering Biologically Active Molecules Into Cells
Methods For Delivering Biologically Active Molecules Into Cells
US Patent:
6974698, Dec 13, 2005
Filed:
Jan 14, 2000
Appl. No.:
09/483434
Inventors:
Jeffery L. Miller - Potomac MD, US
Urszula Wojda - Warsaw, PL
Paul K. Goldsmith - Rockville MD, US
Urszula Wojda - Warsaw, PL
Paul K. Goldsmith - Rockville MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
C12N005/02
US Classification:
435375, 435455, 536 231
Abstract:
Methods for delivering a biologically active molecule into a cell by linking a molecule to the cell surface, wherein the molecule can act as a surface receptor, then complexing the biologically active molecule with a ligand for the surface receptor, and finally contacting the biologically active molecule-ligand complex with the cell surface are disclosed. Delivery of any biologically active molecule, e. g. proteins, enzymes, nucleic acids, hormones, nucleic acids, and oligonucleotides, is contemplated. The use of biotin or biotinylated antibodies as the surface receptor is disclosed. The use of PEI and PEI-avidin conjugates complexed with oligonucleotides for delivery into a directly or indirectly biotinylated cell surface, along with the PEI-avidin-nucleic acid compositions, are disclosed. Primary and cultured cells with a covalently linked surface receptor molecule, such as biotin, on their surfaces are also disclosed.
Identification Of The Dombrock Blood Group Glycoprotein As A Polymorphic Member Of The Adp-Ribosyltransferase Gene Family
Identification Of The Dombrock Blood Group Glycoprotein As A Polymorphic Member Of The Adp-Ribosyltransferase Gene Family
US Patent:
2005010, May 12, 2005
Filed:
Sep 24, 2001
Appl. No.:
10/381325
Inventors:
Jeffery Miller - Potomac MD, US
Alexander Gubin - North Potomac MD, US
Marion Reid - Jamaica Estates NY, US
Alexander Gubin - North Potomac MD, US
Marion Reid - Jamaica Estates NY, US
International Classification:
C12Q001/68, C07H021/04, C12N009/00, A61K039/00, C12N015/74
US Classification:
435006000, 435069100, 435252300, 435183000, 435320100, 424185100, 536023200
Abstract:
The present invention provides an isolated peptide comprising a Dombrock carrier molecule that contains either a Dombrock (a) antigen or a Dombrock (b) antigen. Further, the present invention provides a nucleic acid encoding a Dombruck carrier molecule or fragments thereof. Moreover, a nucleic acid encoding a Dombrock (a) antigen or fragments thereof is provided. The present invention also provides a nucleic acid encoding a Dombrock (b) antigen or fragments thereof. Kits comprising antibodies to either the Dombrock (a) antigen or the Dombrock (b) antigen are also provided. Moreover, kits comprising either the Dombrock (a) antigen or the Dombrock (b) antigen, and kits comprising nucleic acids that encode the Dombrock (a) antigen or the Dombrock (b) antigen are provided. Methods for detecting the Dombrock (a) antigen or the Dombrock (b) antigen, and methods for detecting antibodies specifically binding to the Dombrock (a) antigen or the Dombrock (b) antigen are provided.